Stockreport

Neurotrope to Participate in the Sachs Associates 2nd Annual Neuroscience Innovation Forum

NextTrip, Inc.  (NTRP) 
PDF NEW YORK, Jan. 3, 2019 /PRNewswire/ -- Neurotrope Inc. (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseas [Read more]